ArticleVaccine2011
Missed clinical opportunities: provider recommendations for HPV vaccination for 11-12 year old girls are limited.
Article in Vaccine, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 118 papers, 2 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
HPV Vaccination: An Investigation of Physician Reminders and Recommendation Scripts
HPV Vaccination: Evaluation of Reminder Prompts for Doses 2 & 3
Who cites it
118 citing papers in PubMed, 2 syntheses or guidelines pooled it, 203 citations in OpenAlex.
- US Health Care Clinicians' Knowledge, Attitudes, and Practices Regarding Human Papillomavirus Vaccination: A Qualitative Systematic Review.Academic pediatrics · 2018Pooled it
- Provider communication about HPV vaccination: A systematic review.Human vaccines & immunotherapeutics · 2016Pooled it
- Trial
- Announcements Versus Conversations to Improve HPV Vaccination Coverage: A Randomized Trial.Pediatrics · 2017Trial
- Healthcare providers' beliefs and attitudes regarding risk compensation following HPV vaccination.Papillomavirus research (Amsterdam, Netherlands) · 2016Trial
- Effect of decision support on missed opportunities for human papillomavirus vaccination.American journal of preventive medicine · 2014Trial
- Comparing in-person and webinar delivery of an immunization quality improvement program: a process evaluation of the adolescent AFIX trial.Implementation science : IS · 2014Trial
- Effectiveness of decision support for families, clinicians, or both on HPV vaccine receipt.Pediatrics · 2013Trial
- Beyond the check-up: how well-child exams, pediatric specialists, and provider recommendations can close HPV vaccine gaps for Chinese American Teens.Cancer causes & control : CCC · 2026Article
- Revealing the Crucial Role of Healthcare Providers in HPV Vaccine Uptake in Filipino American Adolescents: Insights from the National Immunization Survey-Teen, 2015-2019.Journal of racial and ethnic health disparities · 2025Article
- Article
- Article
- Implementation barriers and considerations for recommending and administering the human papillomavirus (HPV) vaccination in oncology settings.Journal of cancer survivorship : research and practice · 2024Article
- Racial, Ethnic, and Gender Differences in the Timing of Initiating the HPV Vaccine in the United States: the Case of Southeast Asian Americans.Journal of racial and ethnic health disparities · 2024Article
- Barriers to the assessment and recommendation of HPV vaccination among healthcare providers in Texas.Vaccine: X · 2024Article
- Understanding Clinic and Community Member Experiences with Implementation of Evidence-Based Strategies for HPV Vaccination in Safety-Net Primary Care Settings.Prevention science : the official journal of the Society for Prevention Research · 2024Article
- Endometrial Cancer Knowledge and Guideline-Concordant Practice Patterns Among First-Line Providers.Journal of women's health (2002) · 2023Article
- Primary care Providers' approaches to cervical cancer screening in Muslim females.Preventive medicine reports · 2023Article
- Article
- Feasibility of Instituting a Clinical Otolaryngology Human Papillomavirus (HPV) Vaccination Program.The Laryngoscope · 2023Article
58 more citing papers are in PubMed but not listed here.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors at 5 institutions in 1 country.
Funding
Abstract
objectiveThe purpose of this study was to determine the prevalence of physician recommendation of human papillomavirus (HPV) vaccination in early (ages 11-12), middle (13-17), and late adolescent/young adult (18-26) female patients by physician specialty, and to identify factors associated with recommendation in early adolescents.
methodsA 38-item survey was conducted April 2009 through August 2009 among a nationally representative random sample of 1538 Family Physicians, Pediatricians, and Obstetricians and Gynecologists obtained from the American Medical Association Physician Masterfile. A multivariable model was used to assess factors associated with frequency of physician recommendation of HPV vaccination ("always"=76-100% of the time vs. other=0-75%) within the past 12 months.
resultsCompleted surveys were received from 1013 physicians, including 500 Family Physicians, 287 Pediatricians, and 226 Obstetricians and Gynecologists (response rate=67.8%). Across the specialties, 34.6% of physicians reported they "always" recommend the HPV vaccine to early adolescents, 52.7% to middle adolescents, and 50.2% to late adolescents/young adults. The likelihood of "always" recommending the HPV vaccine was highest among Pediatricians for all age groups (P<0.001). Physician specialty, age, ethnicity, reported barriers, and Vaccines for Children provider status were significantly associated with "always" recommending HPV vaccination for early adolescents.
conclusionsFindings suggest missed clinical opportunities for HPV vaccination, and perceived barriers to vaccination may drive decisions about recommendation. Results suggest the need for age and specialty targeted practice and policy level interventions to increase HPV vaccination among US females.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.